Revvity Inc

詳細情報 Revvity Inc 企業名

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

企業情報

企業コードRVTY

会社名Revvity Inc

上場日Jul 06, 1965

設立日1947

最高経営責任者「CEO」Dr. Prahlad R. Singh, Ph.D.

従業員数11000

証券種類Ordinary Share

決算期末Jul 06

本社所在地77 4Th Avenue

都市WALTHAM

証券取引所NYSE Consolidated

国United States of America

郵便番号02451

電話番号17816636900

ウェブサイトhttps://www.revvity.com/

企業コードRVTY

上場日Jul 06, 1965

設立日1947

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Prahlad R. Singh, Ph.D.

President, Chief Executive Officer, Director

106.26K

+17.81%

Mr. Alexandros P. (Alexis) Michas

Independent Non-Executive Chairman of the Board

45.44K

+6.67%

Mr. Joel S. Goldberg

Senior Vice President - Administration, General Counsel, Secretary

37.69K

+12.84%

Dr. Peter Barrett, Ph.D.

Independent Director

26.01K

+10.22%

Mr. Maxwell Krakowiak

Chief Financial Officer, Senior Vice President

23.36K

+628.47%

Mr. Tajinder S. Vohra

Senior Vice President - Global Operations

22.63K

+137.66%

Ms. Miriame Victor

Chief Commercial Officer, Senior Vice President

14.29K

+61.74%

Ms. Pascale Witz

Independent Director

13.71K

+21.36%

Mr. Michael A. Klobuchar

Independent Director

5.09K

+90.13%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

5.09K

+90.13%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Prahlad R. Singh, Ph.D.

President, Chief Executive Officer, Director

106.26K

+17.81%

Mr. Alexandros P. (Alexis) Michas

Independent Non-Executive Chairman of the Board

45.44K

+6.67%

Mr. Joel S. Goldberg

Senior Vice President - Administration, General Counsel, Secretary

37.69K

+12.84%

Dr. Peter Barrett, Ph.D.

Independent Director

26.01K

+10.22%

Mr. Maxwell Krakowiak

Chief Financial Officer, Senior Vice President

23.36K

+628.47%

Mr. Tajinder S. Vohra

Senior Vice President - Global Operations

22.63K

+137.66%

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

FY2018

データなし

地域別USD

会社名

収益

比率

Americas

1.22B

44.39%

United States

1.10B

39.85%

Other Foreign

1.09B

39.72%

Asia

789.33M

28.65%

Europe

742.61M

26.95%

Other

-2.19B

-79.57%

事業別

地域別

データなし

株主

更新時刻: Sat, May 17

株主統計

種類

株主統計

比率

T. Rowe Price Investment Management, Inc.

19.10%

The Vanguard Group, Inc.

12.16%

T. Rowe Price Associates, Inc.

7.96%

BlackRock Institutional Trust Company, N.A.

5.15%

Janus Henderson Investors

5.09%

Other

50.54%

株主統計

比率

T. Rowe Price Investment Management, Inc.

19.10%

The Vanguard Group, Inc.

12.16%

T. Rowe Price Associates, Inc.

7.96%

BlackRock Institutional Trust Company, N.A.

5.15%

Janus Henderson Investors

5.09%

Other

50.54%

種類

株主統計

比率

Investment Advisor

57.72%

Investment Advisor/Hedge Fund

33.49%

Hedge Fund

2.43%

Bank and Trust

1.67%

Pension Fund

1.63%

Research Firm

1.35%

Sovereign Wealth Fund

1.04%

Individual Investor

0.32%

Family Office

0.05%

Other

0.30%

機関投資家保有株

更新時刻: Mon, Jan 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

1228

115.38M

97.87%

-1.88M

2024Q4

1277

114.54M

95.28%

-3.97M

2024Q3

1253

112.35M

91.11%

-5.77M

2024Q2

1249

112.44M

91.13%

-1.63M

2024Q1

1287

107.57M

87.09%

-8.24M

2023Q4

1315

109.29M

88.55%

-2.41M

2023Q3

1347

106.10M

85.47%

-6.10M

2023Q2

1383

106.88M

85.21%

-9.65M

2023Q1

1406

108.31M

85.69%

-5.19M

2022Q4

1441

108.60M

86.00%

-7.85M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

T. Rowe Price Investment Management, Inc.

20.76M

17.28%

+2.97M

+16.69%

Dec 31, 2024

The Vanguard Group, Inc.

14.24M

11.85%

+157.96K

+1.12%

Dec 31, 2024

T. Rowe Price Associates, Inc.

7.46M

6.21%

+1.15M

+18.27%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

6.01M

5%

-158.82K

-2.58%

Dec 31, 2024

Janus Henderson Investors

6.36M

5.29%

+23.65K

+0.37%

Dec 31, 2024

EdgePoint Investment Group Inc.

4.06M

3.38%

+1.37M

+51.10%

Dec 31, 2024

State Street Global Advisors (US)

5.17M

4.3%

-13.79K

-0.27%

Dec 31, 2024

Mitsubishi UFJ Asset Management Co., Ltd.

3.38M

2.82%

+69.03K

+2.08%

Dec 31, 2024

Geode Capital Management, L.L.C.

2.90M

2.41%

+37.67K

+1.32%

Dec 31, 2024

Capital Research Global Investors

2.99M

2.49%

-97.75K

-3.17%

Dec 31, 2024

詳細を見る

関連ETF

更新時刻: Fri, Jun 6

銘柄名

比率

Otter Creek Focus Strategy ETF

2.72%

T Rowe Price Capital Appreciation Equity ETF

2.15%

First Trust Indxx Medical Devices ETF

1.81%

Invesco S&P 500 Equal Weight Health Care ETF

1.37%

VanEck Morningstar SMID Moat ETF

1.21%

Simplify Health Care ETF

0.98%

Franklin Genomic Advancements ETF

0.97%

Janus Henderson US Sustainable Equity ETF

0.9%

ROBO Global Healthcare Technology & Innovation ETF

0.86%

LeaderShares AlphaFactor US Core ETF

0.84%

詳細を見る

Otter Creek Focus Strategy ETF

比率2.72%

T Rowe Price Capital Appreciation Equity ETF

比率2.15%

First Trust Indxx Medical Devices ETF

比率1.81%

Invesco S&P 500 Equal Weight Health Care ETF

比率1.37%

VanEck Morningstar SMID Moat ETF

比率1.21%

Simplify Health Care ETF

比率0.98%

Franklin Genomic Advancements ETF

比率0.97%

Janus Henderson US Sustainable Equity ETF

比率0.9%

ROBO Global Healthcare Technology & Innovation ETF

比率0.86%

LeaderShares AlphaFactor US Core ETF

比率0.84%

配当金

過去5年間の配当金総支払額は 168.35M 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Oct 24, 2024

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025

Jan 17, 2025

Feb 07, 2025

Jan 17, 2025

Jul 25, 2024

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024

Oct 18, 2024

Nov 08, 2024

Oct 18, 2024

Apr 25, 2024

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024

Jul 19, 2024

Aug 09, 2024

Jul 19, 2024

Jan 25, 2024

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024

Apr 19, 2024

May 10, 2024

Apr 18, 2024

Oct 26, 2023

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024

Jan 19, 2024

Feb 09, 2024

Jan 18, 2024

Jul 21, 2023

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023

Oct 20, 2023

Nov 10, 2023

Oct 19, 2023

Apr 25, 2023

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 11, 2023 going ex on Jul 20, 2023

Jul 21, 2023

Aug 11, 2023

Jul 20, 2023

Jan 26, 2023

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 12, 2023 going ex on Apr 20, 2023

Apr 21, 2023

May 12, 2023

Apr 20, 2023

Oct 27, 2022

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 10, 2023 going ex on Jan 19, 2023

Jan 20, 2023

Feb 10, 2023

Jan 19, 2023

Jul 22, 2022

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 11, 2022 going ex on Oct 20, 2022

Oct 21, 2022

Nov 11, 2022

Oct 20, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

97.700USD

Revvity Inc

97.700

概要

企業名